HomeIPA • NASDAQ
add
Immunoprecise Antibodies Ltd
Previous close
$1.89
Day range
$1.77 - $1.89
Year range
$0.27 - $2.41
Market cap
85.39M USD
Avg Volume
1.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | 6.98M | 8.08% |
Operating expense | 5.93M | -15.11% |
Net income | -2.16M | 87.73% |
Net profit margin | -30.96 | 88.64% |
Earnings per share | — | — |
EBITDA | -1.09M | 63.50% |
Effective tax rate | -13.74% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.66M | 208.33% |
Total assets | 44.44M | -25.92% |
Total liabilities | 20.82M | -14.38% |
Total equity | 23.63M | — |
Shares outstanding | 46.15M | — |
Price to book | 3.71 | — |
Return on assets | -8.19% | — |
Return on capital | -9.82% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -2.16M | 87.73% |
Cash from operations | -1.14M | 27.89% |
Cash from investing | -359.00K | 67.69% |
Cash from financing | -418.00K | -137.22% |
Net change in cash | -2.21M | 19.31% |
Free cash flow | -662.62K | 60.65% |
About
Founded
1983
Headquarters
Website
Employees
92
